Pharmaceutical - Boardroom, Anti-virals

Filter

Current filters:

BoardroomAnti-virals

Popular Filters

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

28-04-2014

UK-based antiviral drug discovery and development company reViral has announced the appointment of Professor…

Anti-viralsBiotechnologyBoardroomPharmaceuticalreViralUK

Forest Laboratories announces new appointments to its executive team

16-12-2013

New York-based pharmaceutical company Forest Laboratories (NYSE: FRX) has announced new appointments…

Anti-viralsBoardroomCardio-vascularCNS DiseasesForest LaboratoriesGastro-intestinalsPharmaceuticalRespiratory and PulmonaryUSA

Back to top